Discovery of Novel Multifunctional Molecules for Synergistic Theranostics Based on Vascular Normalization Targets
Molecular Pharmaceutics · 2026
DOI: 10.1021/acs.molpharmaceut.5c01544 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2026. Verfasst von Yanchen Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an 710061, China. Hauptthemen laut MEDLINE: Angiogenesis Inhibitors, Neovascularization, Pathologic, Colorectal Neoplasms, Theranostic Nanomedicine. Die Arbeit nennt 20 Literaturangaben. Gefördert von: Natural Science Basic Research Program of Shaanxi Province, Shaanxi Administration of Traditional Chinese Medicine, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Tumor vascular abnormalities can reduce drug and oxygen delivery and induce tumor resistance. However, it has recently been found that a few antiangiogenic drugs can achieve significant efficacy when combined with chemoradiotherapy, which is contrary to the effect of antiangiogenic drugs in clearing blood vessels. The theory of vascular normalization, originating from clinical observations, has explained this paradox and has become a promising strategy to overcome the bottleneck of tumor treatment, but there is a lack of innovative drugs. Based on the previous identification of the novel vascular normalization target EphrinB2, a synergistic strategy, "vascular normalization─chemotherapy" was proposed. Based on the principle of twin drugs in drug design and the controlled release strategy, we found a new type of vascular normalization-chemotherapy twin drug based on the active molecule QDAU5, which showed good membrane permeability, strong stability, rapid toxic payload release characteristics, and strong inhibitory activity against colorectal tumors. The study further enriches the theory of vascular normalization and promotes its expansion into the field of new drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an 710061, China.
- Department of Hepatobiliary Pancreatic and Splenic Surgery, Baoji Central Hospital, Baoji 721004, China.
ORCID-Profile: Jie Zhang
Förderung
- Natural Science Basic Research Program of Shaanxi Province
- Shaanxi Administration of Traditional Chinese Medicine
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- Key Research and Development Projects of Shaanxi Province
Zitieren
APA
Li, Y., Liu, T., Cheng, W., Zhao, L., Wei, Y., & Zhang, J. (2026). Discovery of Novel Multifunctional Molecules for Synergistic Theranostics Based on Vascular Normalization Targets. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01544
Vancouver
Li Y, Liu T, Cheng W, Zhao L, Wei Y, Zhang J. Discovery of Novel Multifunctional Molecules for Synergistic Theranostics Based on Vascular Normalization Targets. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.5c01544
BibTeX
@article{Li2026,
author = {Li, Yanchen and Liu, Tingting and Cheng, Weihua and Zhao, Lifeng and Wei, Yangchao and Zhang, Jie},
title = {Discovery of Novel Multifunctional Molecules for Synergistic Theranostics Based on Vascular Normalization Targets},
journal = {Molecular Pharmaceutics},
year = {2026},
doi = {10.1021/acs.molpharmaceut.5c01544}
}
EUVIMED